FDA approves new standard of care for kidney cancer

(UT Southwestern Medical Center) The US Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news